Membership Directory

Archemix Corp.

Category: Drug Development
Phone: 617-621-7700
Fax: 617-621-9300
Website: http://www.archemix.com

Archemix is working to accelerate the drug discovery process through application of its proprietary technology in nucleic acid engineering. We will lead the development of tools for proteomics analysis and for biological assays. Riboreporters™ are evolved in the laboratory to recognize specific targets and signal their presence through RNA-catalyzed chemistry. These molecular tools function as in vitro sensors in both solution and chip formats, and can be used to monitor a wide range of targets that includes proteins, metabolites, drugs, toxins, and ions. When expressed in vivo, riboreporters couple the presence of their targets to altered reporter gene expression and thus enable direct monitoring of protein levels and metabolism in both live cells and animals. Archemix' core technology is backed by over one hundred patents and pending applications. Our founders include leaders in the fields of RNA engineering, biosensor development, and drug discovery. For information on partnering, employment, or investment opportunities, send e-mail to archemix.

Back to list